Logo-jpd
J Parathyr Dis. 2016;4(1): 11-12.
  Abstract View: 1718
  PDF Download: 983

Commentary

Fibroblast growth factor 23 and cardiovascular events in chronic kidney disease patients

Fatemeh Yaghoubi 1

1 Department of Nephrology, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran
*Corresponding Author:

Implication for health policy/practice/research/medical education

Disorders of phosphate homeostasis are popular in patients with chronic renal failure. As renal function deteriorates, circulating levels of phosphate and the phosphate-regulatory hormone, fibroblast growth factor (FGF)-23, increase gradually. Higher serum levels of phosphate and FGF 23 are accompanied with an increased risk of adverse outcomes, comprising all-cause mortality and cardiovascular disease. The association of higher levels of FGF 23 and adverse cardiovascular outcomes are commonly independent of serum phosphate levels. High levels of FGF-23, hyperparathyroidism, and hyperphosphatemia have all been related to an increased risk of cardiovascular mortality and morbidity chronic renal failure individuals.

Please cite this paper as: Yaghoubi F. Fibroblast growth factor 23 and cardiovascular events in chronic kidney disease patients. J Parathyr Dis. 2016;4(1):11-12.

First Name
Last Name
Email Address
Comments
Security code


Abstract View: 1719

Your browser does not support the canvas element.


PDF Download: 983

Your browser does not support the canvas element.

ePublished: 20 Feb 2016
EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)